24.21
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Viridian Therapeutics Inc Borsa (VRDN) Ultime notizie
Can machine learning forecast Viridian Therapeutics Inc. recoveryJuly 2025 Breakouts & High Yield Equity Trading Tips - newser.com
Using Ichimoku Cloud for Viridian Therapeutics Inc. technicalsMarket Growth Review & Verified Technical Trade Signals - newser.com
Is this a good reentry point in Viridian Therapeutics Inc.2025 Growth vs Value & AI Based Buy/Sell Signal Reports - newser.com
How Viridian Therapeutics Inc. stock reacts to bond yieldsQuarterly Trade Report & Low Risk Entry Point Guides - newser.com
Thyroid Eye Disease Clinical Trial Pipeline Gains Momentum: 20+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight - GlobeNewswire Inc.
Is Viridian Therapeutics Inc. building a consolidation base2025 Technical Overview & Technical Pattern Based Signals - newser.com
How buybacks impact Viridian Therapeutics Inc. stock value2025 Stock Rankings & AI Forecasted Stock Moves - newser.com
Is Viridian Therapeutics Inc. stock dividend yield sustainableAnalyst Downgrade & Reliable Price Action Trade Plans - newser.com
What machine learning models say about Viridian Therapeutics Inc.Dollar Strength & Fast Gain Stock Trading Tips - newser.com
Tools to monitor Viridian Therapeutics Inc. recovery probability2025 Market WrapUp & Free Risk Controlled Daily Trade Plans - newser.com
Retinitis Pigmentosa Market to Expand Significantly by 2034, States DelveInsight Report | SparingVision SAS, ProQR Therapeutics NV, Viridian Therapeutics Inc, 4D Molecular Therapeutics Inc - The Globe and Mail
Is Viridian Therapeutics Inc. stock reversal real or fakeJuly 2025 Action & Daily Volume Surge Signals - newser.com
What candlestick patterns are forming on Viridian Therapeutics Inc.Forecast Cut & Free Technical Pattern Based Buy Signals - newser.com
Is Viridian Therapeutics Inc. stock attractive for growth ETFsMarket Movement Recap & Fast Entry Momentum Alerts - newser.com
Why Viridian Therapeutics Inc. is moving todayWeekly Trade Recap & Scalable Portfolio Growth Methods - newser.com
Is Viridian Therapeutics Inc. (1S1) stock protected from inflationMarket Risk Report & Pattern Based Trade Signal System - newser.com
Viridian Therapeutics’ (VRDN) Sell (D-) Rating Reiterated at Weiss Ratings - Defense World
Is Viridian Therapeutics Inc. stock safe for conservative investors2025 Dividend Review & Scalable Portfolio Growth Ideas - newser.com
Viridian Therapeutics supports key conferences with sponsorship initiative - Traders Union
Weiss Ratings Reaffirms "Sell (D-)" Rating for Viridian Therapeutics (NASDAQ:VRDN) - MarketBeat
Real time alert setup for Viridian Therapeutics Inc. performanceBear Alert & Real-Time Volume Surge Alerts - newser.com
Will Viridian Therapeutics Inc. (1S1) stock beat growth indexesJuly 2025 Market Mood & Precise Entry and Exit Recommendations - newser.com
Viridian Therapeutics, Inc. $VRDN Shares Acquired by J. Safra Sarasin Holding AG - MarketBeat
Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)October 2, 2025 - BioSpace
Viridian Therapeutics announces inducement grants under Nasdaq Listing Rule - MarketScreener
Voya Investment Management LLC Sells 1,627 Shares of Viridian Therapeutics, Inc. $VRDN - Defense World
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):